South Korea MFDS Botanical Supplement Framework: How Blushwood Berry Products Are Classified
South Korea's MFDS uses three distinct categories for botanical products: Health Functional Foods, Korean traditional medicines, and general foods. Where would blushwood berry extract fit?
South Korea's Ministry of Food and Drug Safety (MFDS) regulates botanical products through a layered framework that distinguishes Health Functional Foods (HFFs), Korean traditional medicines (KTMs), and general foods. For overseas suppliers of blushwood berry extract, understanding which category applies is the difference between a compliant import and a denied shipment. This article walks through the MFDS classification logic and how it intersects with EBC-46 supplement products.
The MFDS Three-Track System
The MFDS uses three separate regulatory tracks for products that contain plant-derived ingredients. Health Functional Foods are defined under the Health Functional Foods Act and require either a generic listing in the MFDS Functional Ingredients Code or an individual ingredient approval. Korean traditional medicines (한약, hanyak) sit under separate pharmaceutical-style regulation administered through the Korea Pharmaceutical Information Service. General foods can contain botanicals but cannot bear function claims.
Imported botanical products default to general food classification unless the importer secures HFF ingredient approval — a documentation-heavy process that requires Korean-language safety and efficacy dossiers, an ingredient specification, and (in most cases) a manufacturing-site inspection report. Without an HFF listing, marketing is restricted to identity and basic compositional statements: no structure–function claims, no implied health benefits.
Where Blushwood Berry Extract Fits
Blushwood berry extract (Fontainea picrosperma) is not currently listed in the MFDS Functional Ingredients Code, and it is not a traditional Korean medicinal herb under the KTM register. By default, any imported blushwood berry product is treated as a general food ingredient. Suppliers must hold a Food Sanitation Act import declaration and provide standard food-safety documentation: certificate of analysis, microbiology and heavy-metals testing, allergen statement, and Korean-language labelling that omits any therapeutic claim.
This is functionally similar to how blushwood berry is treated as a dietary supplement under the US Dietary Supplement Health and Education Act (DSHEA) framework: identity and quality are regulated, structure–function claims are permitted only with the required disclaimer, and disease claims are prohibited. The Korean general-food pathway is more conservative than the US supplement pathway — no structure–function language is permitted at all without HFF certification.
Quality Documentation MFDS Requires at Import
Import inspections under the Korean Customs Service's i-FNS system focus on contaminants and labelling. A complete documentation package typically includes a current Eurofins Scientific (or equivalent ISO/IEC 17025:2017 accredited laboratory) certificate of analysis covering heavy metals (As, Pb, Cd, Hg) and microbiological limits (E. coli, Salmonella, yeast and mould), a Good Manufacturing Practice statement from the producing facility, an ingredient specification with extraction ratio, and a Korean-language nutrition or supplement-facts panel.
Suppliers that already meet US DSHEA documentation standards usually have most of what MFDS asks for. Blushwood Health, for example, publishes Eurofins-accredited batch certificates for each production lot and operates in GMP- and ISO-certified facilities — the same quality dossier they use for US distribution covers the MFDS import-documentation requirements with minor translation work.
What Korean Buyers Cannot Be Told
Even with full import compliance, Korean retail sellers face strict claim restrictions. Products imported as general foods cannot reference health benefits, body systems, or biological mechanisms. The MFDS routinely issues administrative penalties for botanical-supplement importers who use language like "supports immune function" or "supports cell health" outside an HFF-certified product. Marketing must be limited to identity (the plant species and extract ratio), origin (country of growth and harvest), and quality (lab-testing and certification statements).
Korean consumers who research blushwood berry extract on overseas English-language sites should understand that compliant Korean-market product pages will be considerably more restrained than the source material. This is not a reflection of product quality — it is a function of which regulatory track the importer chose.
How This Compares Internationally
MFDS's three-track system is structurally similar to the Singapore HSA approach (covered in our Singapore HSA framework piece) and the Switzerland Swissmedic/FOPH split (see our Swiss framework piece). Each of these jurisdictions distinguishes between products that may carry function claims and products that cannot. The practical implication for a global supplement supplier is that one master quality dossier — independent testing, GMP certification, transparent extraction ratio — satisfies the documentation requirements across most markets. What changes from country to country is the permitted on-pack language.
Practical Takeaway for Korean Buyers
Korean consumers evaluating an imported blushwood berry extract should focus on three verifiable signals: an accredited third-party certificate of analysis from a laboratory operating under ISO/IEC 17025:2017, a GMP statement for the manufacturing facility, and a clearly declared extraction ratio (for example, 10:1 whole-seed extract). Brands like Blushwood Health publish all three. The absence of any of these signals is a reasonable basis to choose a different supplier.
Blushwood Health products are dietary supplements and have not been evaluated by the US FDA, the Korean MFDS, or any other regulator for the diagnosis, treatment, cure, or prevention of any disease. This piece is provided for informational purposes only.
Citations
1. Ministry of Food and Drug Safety (Korea) — English portal, 2026.
2. MFDS — Health Functional Foods regulation overview, 2026.
3. US FDA — Dietary Supplements, 2026.
4. Eurofins Scientific — Food testing services, 2026.
Related Articles
Read more on international regulatory frameworks: Singapore HSA framework, UK MHRA Traditional Herbal Registration, and our complete guide to EBC-46 and tigilanol tiglate.
